A term neonate at 6 hours of life has total serum bilirubin (TSB) of 6 mg/dL. The mother is G2P1 with O negative blood group; the baby is O positive, direct Coombs positive. The baby is well and feeding well. A repeat TSB at 12 hours is 12 mg/dL. According to the AAP 2022 revised nomogram for neonatal jaundice, when should phototherapy be initiated in a term, Coombs-positive (isoimmune hemolytic disease) neonate?

• A When TSB exceeds 15 mg/dL regardless of age in a term neonate
• B Wait until clinical jaundice appears before measuring TSB
• C Phototherapy is only needed when TSB exceeds exchange transfusion threshold
• D Phototherapy threshold is lower in isoimmune hemolytic disease; consider starting at age-specific thresholds that are 1–2 mg/dL below general guidelines ✓

Explanation

The AAP 2022 revised clinical practice guideline on neonatal hyperbilirubinemia introduced neurotoxicity risk factors that lower the phototherapy threshold by approximately 1–2 mg/dL. Isoimmune hemolytic disease (positive direct Coombs, DAT) is a major neurotoxicity risk factor due to rapid bilirubin rise and risk of continued hemolysis. The guideline recommends applying these lower thresholds rather than the standard curves for at-risk newborns, and emphasizes hour-specific TSB plotting on the Bhutani nomogram for risk stratification. The rate of rise (6 mg/dL in 6 hours → 12 mg/dL in 12 hours = 1 mg/dL/hour) also indicates active hemolysis requiring urgent management.

Reference: Ghai Essential Pediatrics, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.